BALA CYNWYD, Pa., March 10, 2016 /PRNewswire/ -- Law Office of
Brodsky & Smith, LLC announces an investigation of GW
Pharmaceuticals plc ("GW Pharmaceuticals" or the "Company") (Nasdaq
-GWPH- News) for potential violations of federal securities laws
and breaches of the GW Pharamceuticals Board's fiduciary
duties.
Click here to learn more
http://brodsky-smith.com/1049-gwph-gw-pharmaceuticals-plc.html, or
call: 877-534-2590. There is no cost or obligation wto you.
The investigation concerns a securities class action lawsuit
commenced in the United States District Court for the Southern
District of New York. The
complaint alleges that: (i) the Defendants made false and
misleading statements including failing to disclose that the
Company lacked effective internal financial controls; (ii) the
company lacked effective controls over completeness and valuation
of clinical trials accruals; and (iii) as a result of the
foregoing, defendants' statements about GW Pharmaceuticals
business, operations, and prospects were false and/or lacked a
reasonable basis at all relevant times. Following the disclosure of
these facts, shares of GW Pharmaceuticals stock declined
significantly.
If you purchased shares of GW Pharmaceuticals between
December 4, 2015 and January 8, 2016, and wish to discuss the
investigation, or if you have any questions, you may e-mail or call
the law office of Brodsky & Smith, LLC by March 21, 2016, who will, without obligation or
cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky
& Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/1049-gwph-gw-pharmaceuticals-plc.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and successfully
recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar
outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-law-office-of-brodsky--smith-llc-announces-investigation-of-gw-pharmaceuticals-plc---gwph-300234223.html
SOURCE Brodsky & Smith, LLC